DSGN - Design Therapeutics, Inc. -  [ ]

Ticker Details
Design Therapeutics, Inc.
IPO Date: March 29, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $685.15M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 3.55%
Avg Daily Range (30 D): $0.61 | 4.37%
Avg Daily Range (90 D): $0.38 | 3.13%
Institutional Daily Volume
Avg Daily Volume: .26M
Avg Daily Volume (30 D): .85M
Avg Daily Volume (90 D): .44M
Trade Size
Avg Trade Size (Sh.): 90
Avg Trade Size (Sh.) (30 D): 75
Avg Trade Size (Sh.) (90 D): 74
Institutional Trades
Total Institutional Trades: 358
Avg Institutional Trade: $1.64M
Avg Institutional Trade (30 D): $1.01M
Avg Institutional Trade (90 D): $1.21M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.14M
Avg Closing Trade (30 D): $.97M
Avg Closing Trade (90 D): $.94M
Avg Closing Volume: 171.54K
 
News
May 18, 2026 @ 11:00 AM
Design Therapeutics Announces Four-Week IV Data fr...
Source: Na
May 17, 2026 @ 8:00 PM
Design Therapeutics to Host Investor Webcast to Re...
Source: Na
Nov 26, 2025 @ 1:00 PM
Design Therapeutics to Participate in Upcoming Inv...
Source: Renee Leck
May 7, 2024 @ 10:30 AM
Design Therapeutics to Participate in the 2024 RBC...
Source: Design Therapeutics, Inc.
Mar 26, 2024 @ 11:37 AM
Design Therapeutics And 2 Other Stocks Under $5 In...
Source: Avi Kapoor
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-1.2 $-.29 $-.27
Diluted EPS $-1.2 $-.29 $-.27
Revenue $M $M $M
Gross Profit
Net Income / Loss $-69.71M $-17.64M $-16M
Operating Income / Loss $-78.76M $-19.71M $-18.17M
Cost of Revenue
Net Cash Flow $-.9M $-4.09M $1.77M
PE Ratio